- Listed department
- Department not confirmed in the reviewed information
Clinical interests
Expert in standardized diagnosis and treatment of SLE, with particular expertise in difficult, critical, and rare SLE cases. Continuously optimizes treatment plans for childhood lupus, using standardized treatment as the core, targeted therapy as the entry point, and steroid discontinuation as the goal, while integrating multidimensional chronic disease management that considers growth and development, physical and mental health, and other factors.
The main conditions treated include various pediatric rheumatic and autoimmune diseases, secondary kidney diseases, and fever of unknown origin (FUO). Areas of particular expertise include systemic lupus erythematosus/lupus nephritis (SLE/LN), juvenile dermatomyositis (JDM), systemic juvenile idiopathic arthritis (SJIA), IgA vasculitis (IgAV), Takayasu arteritis (TA), antineutrophil cytoplasmic antibody-associated vasculitis (AAV), Behçet disease (BD), juvenile localized scleroderma/systemic sclerosis (JLS/SSc), chronic nonbacterial osteomyelitis (CNO), secondary hemophagocytic lymphohistiocytosis/macrophage activation syndrome (secondary HLH/MAS), monogenic autoimmune diseases (monogenic autoimmune diseases/AIDs), and other conditions; also highly proficient in precision targeted therapy and chronic disease management.
Read more
Expert in standardized diagnosis and treatment of SLE, with particular expertise in difficult, critical, and rare SLE cases. Continuously optimizes treatment plans for childhood lupus, using standardized treatment as the core, targeted therapy as the entry point, and steroid discontinuation as the goal, while integrating multidimensional chronic disease management that considers growth and development, physical and mental health, and other factors.
The main conditions treated include various pediatric rheumatic and autoimmune diseases, secondary kidney diseases, and fever of unknown origin (FUO). Areas of particular expertise include systemic lupus erythematosus/lupus nephritis (SLE/LN), juvenile dermatomyositis (JDM), systemic juvenile idiopathic arthritis (SJIA), IgA vasculitis (IgAV), Takayasu arteritis (TA), antineutrophil cytoplasmic antibody-associated vasculitis (AAV), Behçet disease (BD), juvenile localized scleroderma/systemic sclerosis (JLS/SSc), chronic nonbacterial osteomyelitis (CNO), secondary hemophagocytic lymphohistiocytosis/macrophage activation syndrome (secondary HLH/MAS), monogenic autoimmune diseases (monogenic autoimmune diseases/AIDs), and other conditions; also highly proficient in precision targeted therapy and chronic disease management.